The PE Ratio as of December 2025 (TTM) for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) is 9.15

According to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s latest financial reports and current stock price. The company's current PE Ratio is 9.15. This represents a change of -2913.80% compared to the average of -0.33 of the last 4 quarters.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) Historical PE Ratio (quarterly & annually)

How has 0874.HK PE Ratio performed in the past?

The mean historical PE Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited over the last ten years is 18.16. The current 9.15 PE Ratio has changed 4.94% with respect to the historical average. Over the past ten years (40 quarters), 0874.HK's PE Ratio was at its highest in in the December 2018 quarter at 8.17K. The PE Ratio was at its lowest in in the December 2024 quarter at -35.71.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) Average PE Ratio

How has 0874.HK PE Ratio performed in the past?

The current PE Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) PE Ratio vs. Peers

How is 0874.HK’s PE Ratio compared to its peers?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s PE Ratio is less than China Resources Pharmaceutical Group Limited (9.35), less than Livzon Pharmaceutical Group Inc. (14.35), greater than XtalPi Holdings Ltd (-170.80), less than Grand Pharmaceutical Group Limited (13.98), less than China Medical System Holdings Limited (17.45), greater than The United Laboratories International Holdings Limited (6.41), greater than Xuanzhubio-b (-60.31), greater than Sinopharm Group Co. Ltd. (8.12), greater than Shanghai Junshi Biosciences Co., Ltd. (-37.70), greater than HUTCHMED (China) Limited (4.98),

Build a custom stock screener for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.